DL-Norleucine

DL-Norleucine is a free, non-proteinogenic amino acid in the aliphatic amino acid class, featuring a straight-chain side chain (n-butyl substituent) attached to the alpha carbon bearing an amino group and a carboxyl group. The molecule is present as a DL (racemic) mixture, so it contains both stereochemical forms at the alpha carbon, and its side chain is hydrophobic and chemically inert under many peptide-synthesis conditions. DL-Norleucine is used as a building block in peptide synthesis and structure-activity studies to probe the effects of increased side-chain length and hydrophobicity, and it can also serve as a reference standard in analytical method development for amino acid profiling.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP08503

CAS No:616-06-8

Synonyms/Alias:6154-45-6;BZ-TYR-PNA;(S)-N-(3-(4-Hydroxyphenyl)-1-((4-nitrophenyl)amino)-1-oxopropan-2-yl)benzamide;n|A-benzoyl-n-(4-nitrophenyl)-l-tyrosinamide;BTPNA;(2S)-3-(4-HYDROXYPHENYL)-N-(4-NITROPHENYL)-2-(PHENYLFORMAMIDO)PROPANAMIDE;AC1L4NUQ;AC1Q1ZF5;Benzoyltyrosine4-nitroanilide;SCHEMBL1351202;Benzoyl-L-tyrosinep-nitroanilide;Benzoyl-L-tyrosine4-nitroanilide;CJERUMAUMMIPRF-FQEVSTJZSA-N;MolPort-004-964-835;ZINC4899459;6500AH;AR-1K8265;KM0522;AKOS016845836;AJ-52548;AK135287;AM027333;OR072202;KB-211901;FT-0659972

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C22H19N3O5
M.W/Mr.
131.2

DL-Norleucine is a six-carbon aliphatic amino acid (2-aminohexanoic acid) supplied as a racemic mixture, providing a chiral amino acid framework where stereochemistry is present at the α-carbon but supplied in both enantiomeric forms. The molecule contains a primary amine and a carboxylic acid, enabling standard amino acid chemistry such as salt formation, esterification, and amide bond formation after appropriate activation. The unbranched side chain lacks heteroatoms and aromatic functionality, which makes it a clean aliphatic surrogate for hydrophobic residue replacement in peptide and protein engineering contexts. As an amino acid intermediate, DL-norleucine can participate in peptide coupling and downstream derivatization while supporting protecting-group strategies that control the reactivity of the amino and carboxyl functionalities.

1. Peptide Synthesis

DL-Norleucine is applied in peptide building workflows where incorporation of an aliphatic hydrophobic residue is required for peptide coupling chemistry and sequence design. The amino and carboxyl groups allow conversion to protected amino acid derivatives or activated carboxyl forms, supporting amide bond formation under standard peptide coupling conditions after orthogonal protection of the amine. Racemic availability can be used in exploratory peptide libraries, where side-chain hydrophobicity and backbone steric effects are probed without enforcing a single stereochemical outcome. Downstream, DL-norleucine-containing peptides and peptide fragments serve as research materials for assessing residue substitution effects in synthetic peptide science and method development.

2. Amino Acid Derivatization

DL-Norleucine is used as a starting material for amino acid derivatization routes that generate esters, amides, and protected intermediates for subsequent synthetic steps. The primary amine can be protected (for example, as an N-protected derivative) to enable selective functional group transformations on the carboxyl side, while carboxyl activation supports conversion into coupling-ready species. The straight-chain side chain can be further functionalized through chemistries that introduce handles for tagging, crosslinking, or polymer attachment, while maintaining the amino acid core for predictable downstream reactivity. Resulting derivatives function as chemical biology reagents, intermediate building blocks, or process-compatible substrates for fine chemical synthesis.

3. Protein Engineering Studies

DL-Norleucine is relevant to protein engineering and biochemical research where hydrophobic residue scanning or replacement of methionine-like aliphatic character is investigated in a controlled manner. The amino acid backbone supports incorporation into peptide segments and can be used to generate model peptides that mimic local sequence environments around hydrophobic side chains. Racemic composition may be leveraged for screening or for generating material sets where stereochemical dependence is evaluated alongside physicochemical properties such as hydrophobic packing and conformational preferences. Synthesized norleucine-containing constructs can then be used as substrates or reference materials in studies of protein-ligand interactions, folding propensities, or sequence-dependent behavior.

4. Chemical Manufacturing Intermediates

DL-Norleucine is utilized in industrial chemical manufacturing as a chiral amino acid intermediate precursor for producing protected amino acid derivatives and downstream functional chemicals. The presence of both amine and carboxyl groups supports staged manufacturing routes in which protection, activation, and deprotection steps are sequenced to control reactivity and minimize side reactions. The unbranched aliphatic side chain can be carried through process operations to yield aliphatic amide, ester, or polymerizable intermediates that retain predictable functional group chemistry. Downstream products include peptide synthesis intermediates, specialty chemical building blocks, and feedstocks for producing aliphatic amino acid-derived materials used in applied chemical development.

5. Analytical Research Standards

DL-Norleucine is suitable for analytical research where amino acid standards, calibration references, and derivatization targets are needed to support method development and compositional analysis. The amino acid's defined functional groups enable conversion to detectable derivatives for chromatographic or spectrometric workflows, and the racemic nature can be advantageous when assessing total norleucine content without requiring enantiomeric separation. The stable aliphatic structure can serve as a reference for monitoring derivatization efficiency and recovery in amino acid analysis, including workflows that target primary amino acids. Analytical use of DL-norleucine-containing materials supports quality control of peptide hydrolysates, amino acid feedstocks, and intermediate streams in research and production environments.

Abbr
H-DL-Nle-OH
InChI
1S/C22H19N3O5/c26-19-12-6-15(7-13-19)14-20(24-21(27)16-4-2-1-3-5-16)22(28)23-17-8-10-18(11-9-17)25(29)30/h1-13,20,26H,14H2,(H,23,28)(H,24,27)/t20-/m0/s1
InChI Key
CJERUMAUMMIPRF-FQEVSTJZSA-N
Canonical SMILES
C1=CC=C(C=C1)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC3=CC=C(C=C3)[N+](=O)[O-]

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Modification ServicesPeptide Analysis ServicesPeptide Synthesis ServicesPeptide Nucleic Acids SynthesisEpitope Mapping ServicesCustom Conjugation ServicePeptide CDMOcGMP Peptide Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers